Cargando…
Synovial tissue hypoxia and inflammation in vivo
INTRODUCTION: Hypoxia is a microenvironmental feature in the inflamed joint, which promotes survival advantage for cells. The aim of this study was to examine the relationship of partial oxygen pressure in the synovial tissue (tPO(2)) in patients with inflammatory arthritis with macroscopic/microsco...
Autores principales: | Ng, C T, Biniecka, M, Kennedy, A, McCormick, J, FitzGerald, O, Bresnihan, B, Buggy, D, Taylor, C T, O'Sullivan, J, Fearon, U, Veale, D J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946116/ https://www.ncbi.nlm.nih.gov/pubmed/20439288 http://dx.doi.org/10.1136/ard.2009.119776 |
Ejemplares similares
-
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies
por: Moran, Ellen M, et al.
Publicado: (2009) -
Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis
por: Biniecka, Monika, et al.
Publicado: (2011) -
Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss
por: Fearon, U, et al.
Publicado: (2005) -
Dysregulated bioenergetics: a key regulator of joint inflammation
por: Biniecka, M, et al.
Publicado: (2016) -
The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
por: Mullan, RH, et al.
Publicado: (2005)